
About Me
Dr. Rachel Arakawa is an Assistant Professor in the Division of Endocrinology, Diabetes, and Bone disease. She completed her residency training in Internal Medicine and fellowship training in Endocrinology at the Columbia University Medical Center of New York Presbyterian Hospital. Her clinical interests include thyroid, adrenal, pituitary, parathyroid, and metabolic bone disease. She has conducted research in obesity and the effects of bariatric surgery on hormones of glucose and energy homeostasis. She has expertise in a wide variety of endocrine disorders and is committed to providing exceptional care to patients.
The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.
Language
English
Position
ASSISTANT CLINICAL PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
Publications
Selected Publications
- Obesity is independently associated with septic shock, renal complications, and mortality in a multiracial patient cohort hospitalized with COVID-19. Gabrielle Page-Wilson, Rachel Arakawa, Samantha Nemeth, Fletcher Bell, Zachary Girvin, Mary Claire Tuohy, Max Lauring, Blandine Laferrère, Gissette Reyes-Soffer, Karthik Natarajan, Rui Jun Chen, Paul Kurlansky, Judith Korner. PLoS ONE
- Prospective study of gut hormone and metabolic changes after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Rachel Arakawa, Gerardo Febres, Bin Cheng, Abraham Krikhely, Marc Bessler, Judith Korner. PLoS ONE
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.